Benitec Biopharma Inc.
SEC Filing List
BNTC CIK: 0001808898
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| 10-K/A | Amendment to annual report pursuant to S... | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/20/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2026 | |
| 8-K | Current report filing | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2026 | |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/11/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 02/10/2026 | ||
| S-3 | Registration statement for specified tra... | Benitec Biopharma Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/30/2026 | |
| SCHEDULE 13G/A | 01/29/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Mates Sharon | PROSKAUER ROSE LLP /fa | 01/26/2026 | |
| No record found. | |||||
| Load More | |||||
